Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Forkhead BioTherapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Forkhead BioTherapeutics

Forkhead BioTherapeutics

Seed

Forkhead Bio: A biotech firm innovating cell conversion therapies for insulin-dependent diabetes.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Forkhead BioTherapeutics, founded with a mission to harness the intrinsic capabilities of cell conversion and regeneration, aims to develop transformative therapies that significantly improve patients' lives. The company focuses on innovative biotechnological solutions, with its first target indication being insulin-dependent diabetes. By leveraging advanced cell therapy techniques, Forkhead BioTherapeutics seeks to offer groundbreaking treatments that address critical unmet medical needs in the diabetes market.

Notable affiliated individuals and investors include leading experts in biotechnology and regenerative medicine, although specific names are not publicly disclosed. Key achievements of Forkhead BioTherapeutics include significant advancements in cell conversion technology and promising preclinical results that have garnered attention within the biotech community. The overall impact of the company lies in its potential to revolutionize diabetes treatment, offering hope for millions of patients reliant on insulin therapy.

Forkhead BioTherapeutics - Similar Companies

SymbioCellTech logo

SymbioCellTech

symbiocelltech.com

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

Spheringenics logo

Spheringenics

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

ViaCyte logo

ViaCyte

Legend Biotech logo

Legend Biotech

legendbiotech.com

Forge Biologics logo

Forge Biologics

forgebiologics.com

Cellevolve Bio logo

Cellevolve Bio

cellevolve.com

Throne Biotechnologies logo

Throne Biotechnologies

thronebio.com

Appia Bio logo

Appia Bio

appiabio.com

MelliCell logo

MelliCell

mellicell.com

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

HebeCell logo

HebeCell

hebecellcorp.com

Apic Bio logo

Apic Bio

Encellin logo

Encellin

encellin.com

Forkhead BioTherapeutics - Quick Facts

Who are Forkhead BioTherapeutics' competitors?

Companies similar to Forkhead BioTherapeutics include SymbioCellTech, Stemson Therapeutics, Spheringenics and Cell BioEngines.

When was Forkhead BioTherapeutics founded?

Forkhead BioTherapeutics was founded in 2017.

Where is Forkhead BioTherapeutics' headquarters located?

Forkhead BioTherapeutics' headquarters is located in New York City, NY, US.

How much has Forkhead BioTherapeutics raised to-date?

As of Mar 20, 2019, Forkhead BioTherapeutics has raised a total of $1M (USD).

How many employees does Forkhead BioTherapeutics have?

Forkhead BioTherapeutics has 2 employees as of Feb 4, 2024.

Forkhead BioTherapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cell Therapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research